CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

When rice is in its flowering and grain-filling stages, it is more sensitive to high nighttime temperatures than high daytime ...

Researchers explored the role of the TLE6 protein in male fertility using a novel mouse model. TLE6 deficiency caused ...

Discover how the synergy between AI and cell-free systems is driving a new era in biopharma innovation, accelerating drug ...